{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "19232320", "DateCompleted": {"Year": "2009", "Month": "04", "Day": "20"}, "DateRevised": {"Year": "2012", "Month": "11", "Day": "15"}, "Article": {"ArticleDate": [{"Year": "2009", "Month": "02", "Day": "14"}], "Language": ["eng"], "ELocationID": ["10.1016/j.bbrc.2009.02.033"], "Journal": {"ISSN": "1090-2104", "JournalIssue": {"Volume": "381", "Issue": "2", "PubDate": {"Year": "2009", "Month": "Apr", "Day": "03"}}, "Title": "Biochemical and biophysical research communications", "ISOAbbreviation": "Biochem Biophys Res Commun"}, "ArticleTitle": "Lupeol induces p53 and cyclin-B-mediated G2/M arrest and targets apoptosis through activation of caspase in mouse skin.", "Pagination": {"StartPage": "253", "EndPage": "258", "MedlinePgn": "253-8"}, "Abstract": {"AbstractText": ["Lupeol, present in fruits and medicinal plants, is a biologically active compound that has been shown to have various pharmacological properties in experimental studies. In the present study, we demonstrated the modulatory effect of lupeol on 7,12-dimethylbenz[a]anthracene (DMBA)-induced alterations on cell proliferation in the skin of Swiss albino mice. Lupeol treatment showed significant (p < 0.05) preventive effects with marked inhibition at 48, 72, and 96 h against DMBA-mediated neoplastic events. Cell-cycle analysis showed that lupeol-induced G2/M-phase arrest (16-37%) until 72 h, and these inhibitory effects were mediated through inhibition of the cyclin-B-regulated signaling pathway involving p53, p21/WAF1, cdc25C, cdc2, and cyclin-B gene expression. Further lupeol-induced apoptosis was observed, as shown by an increased sub-G1 peak (28%) at 96 h, with upregulation of bax and caspase-3 genes and downregulation of anti-apoptotic bcl-2 and survivin genes. Thus, our results indicate that lupeol has novel anti-proliferative and apoptotic potential that may be helpful in designing strategies to fight skin cancer."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Proteomics Laboratory, Indian Institute of Toxicology Research, Council of Scientific & Industrial Research, P.O. Box 80, M.G. Marg, Lucknow-226001, UP, India."}], "Identifier": [], "LastName": "Nigam", "ForeName": "Nidhi", "Initials": "N"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Prasad", "ForeName": "Sahdeo", "Initials": "S"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "George", "ForeName": "Jasmine", "Initials": "J"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Shukla", "ForeName": "Yogeshwer", "Initials": "Y"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Biochem Biophys Res Commun", "NlmUniqueID": "0372516", "ISSNLinking": "0006-291X"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Cyclin B"}, {"RegistryNumber": "0", "NameOfSubstance": "Pentacyclic Triterpenes"}, {"RegistryNumber": "0", "NameOfSubstance": "Triterpenes"}, {"RegistryNumber": "0", "NameOfSubstance": "Tumor Suppressor Protein p53"}, {"RegistryNumber": "EC 3.4.22.-", "NameOfSubstance": "Caspase 3"}, {"RegistryNumber": "O268W13H3O", "NameOfSubstance": "lupeol"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": [], "DescriptorName": "Apoptosis"}, {"QualifierName": ["biosynthesis", "genetics"], "DescriptorName": "Caspase 3"}, {"QualifierName": ["drug effects", "genetics"], "DescriptorName": "Cell Division"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Proliferation"}, {"QualifierName": ["genetics"], "DescriptorName": "Cyclin B"}, {"QualifierName": ["genetics"], "DescriptorName": "Enzyme Activation"}, {"QualifierName": ["genetics"], "DescriptorName": "G2 Phase"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred Strains"}, {"QualifierName": [], "DescriptorName": "Pentacyclic Triterpenes"}, {"QualifierName": ["drug effects", "enzymology", "pathology"], "DescriptorName": "Skin"}, {"QualifierName": ["prevention & control"], "DescriptorName": "Skin Neoplasms"}, {"QualifierName": ["drug effects"], "DescriptorName": "Transcription, Genetic"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Triterpenes"}, {"QualifierName": ["genetics"], "DescriptorName": "Tumor Suppressor Protein p53"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2009", "Month": "1", "Day": "30"}, {"Year": "2009", "Month": "2", "Day": "8"}, {"Year": "2009", "Month": "2", "Day": "24", "Hour": "9", "Minute": "0"}, {"Year": "2009", "Month": "2", "Day": "24", "Hour": "9", "Minute": "0"}, {"Year": "2009", "Month": "4", "Day": "21", "Hour": "9", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["19232320", "10.1016/j.bbrc.2009.02.033", "S0006-291X(09)00286-1"]}}], "PubmedBookArticle": []}